Recent price decline is 10% Ajiron Health Co., Ltd. (NYSE:AGL) stock may have disappointed insiders who bought US$747.9K worth of shares at an average price of US$11.17 over the last 12 months. Insiders buy investments with the expectation that the value will increase over time. However, due to recent losses, the value of the initial investment is now only USD 356,400, which is not a significant amount.
While we don't believe shareholders should simply track insider transactions, we think it's perfectly logical to continue to monitor insider activity.
See our latest analysis on agilon's health status.
Insider transactions in agilon health over the past 12 months
The biggest purchase by insiders in the last twelve months was when President Steven Sell bought US$498k worth of shares at a price of US$11.14 per share. So it's clear that insiders wanted to buy at a higher price than the current share price ($5.32). Their views may have changed after the acquisition, but this at least suggests they were confident in the company's future. We always pay attention to the prices insiders pay when buying stocks. Generally, if you paid more than the current price, it's more reassuring because it suggests you saw value even at a higher level.
Over the past 12 months, Agilon Health officials have been buying, but not selling, stock. The chart below depicts insider transactions (by companies and individuals) over the past year. Click on the chart to see all individual trades, including stock price, individual, and date.
Agilon Health isn't the only stock that insiders are buying.For people who like searching succeed in investing this free This list of growing companies with recent insider purchasing may be just the ticket.
Insider ownership of agilon health
Looking at the total insider shares in a company can help you determine whether they are well aligned with common shareholders. Typically, the higher the insider ownership, the more likely it is that insiders are incentivized to build the company for the long term. Insiders own 1.3% of Agilon Health shares, worth approximately US$28m. This is a strong but not significant level of insider ownership, but it's enough to indicate some alignment between management and smaller shareholders.
So what do agilon health's insider transactions tell us?
It doesn't make much sense to see that no insiders traded in Agilon Health stock in the last quarter. On a brighter note, last year's trading was encouraging. Insiders have a vested interest in Ajiron's health, and their transactions do not cause us concern. We like to know what's going on with insider ownership and transactions, but we also always consider what risks a stock faces before making any investment decisions. In terms of investment risk, We've identified 2 warning signs Leveraging agilon health and understanding these should be part of your investment process.
of course, You may find a great investment if you look elsewhere. So take a look at this free List of interesting companies.
For the purposes of this article, insiders are individuals who report their transactions to the relevant regulatory body. The Company currently only accounts for open market transactions and private dispositions of direct profits, and does not account for derivative transactions or indirect profits.
Have feedback on this article? Curious about its content? contact Please contact us directly. Alternatively, email our editorial team at Simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts using only unbiased methodologies, and articles are not intended to be financial advice. This is not a recommendation to buy or sell any stock, and does not take into account your objectives or financial situation. We aim to provide long-term, focused analysis based on fundamental data. Note that our analysis may not factor in the latest announcements or qualitative material from price-sensitive companies. Simply Wall St has no position in any stocks mentioned.
